We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
-3.68%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$44.3B
AUM Growth
-$9.51B
(-18%)
Cap. Flow
-$5.48B
Cap. Flow
% of AUM
-12.38%
Top 10 Holdings %
Top 10 Hldgs %
12.78%
Holding
2,408
New
212
Increased
800
Reduced
967
Closed
238
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$160M |
| 2 |
S&P Global
SPGI
|
+$159M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$123M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$111M |
| 5 |
Pfizer
PFE
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$1.01B |
| 2 |
NBIS
Nebius Group N.V.
NBIS
|
+$257M |
| 3 |
Chevron
CVX
|
+$236M |
| 4 |
ExxonMobil
XOM
|
+$224M |
| 5 |
AbbVie
ABBV
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.65% |
| 2 | Technology | 17.13% |
| 3 | Financials | 12.56% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Industrials | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Morgan Stanley
MS
$318B
| $3.13M | 0.01% |
35,787
-54,074
| -60% | -$5.22M |
|
902
Neurocrine Biosciences
NBIX
$15.2B
| $3.1M | 0.01% |
33,110
-4,570
| -12% | -$387K |
|
|
CIVI
903
DELISTED
Civitas Resources
CIVI
| $3.1M | 0.01% |
51,835
-15,735
| -23% | -$856K |
|
904
Ocular Therapeutix
OCUL
$2.17B
| $3.08M | 0.01% |
+622,280
| New | +$3.45M |
|
905
Suburban Propane Partners
SPH
$1.13B
| $3.07M | 0.01% |
190,741
-80,105
| -30% | -$1.21M |
|
906
Emcor
EME
$32.6B
| $3.06M | 0.01% |
27,164
+17,483
| +181% | +$2.06M |
|
|
WRK
907
DELISTED
WestRock Company
WRK
| $3.04M | 0.01% |
64,616
-45,430
| -41% | -$2.08M |
|
908
Everest Group
EG
$14.5B
| $3.04M | 0.01% |
10,080
+448
| +5% | +$129K |
|
|
GRCL
909
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $3.03M | 0.01% |
1,298,578
| – | – |
|
|
ELAT
910
DELISTED
Elanco Animal Health Incorporated 5.00% Tangible Equity Units
ELAT
| $3.01M | 0.01% |
73,991
| – | – |
|
911
Flowers Foods
FLO
$1.3B
| $3.01M | 0.01% |
117,132
+66,253
| +130% | +$1.8M |
|
912
Advanced Energy
AEIS
$10.1B
| $3.01M | 0.01% |
34,957
-683
| -2% | -$59.1K |
|
913
Avis
CAR
$4.13B
| $3M | 0.01% |
11,383
+696
| +7% | +$140K |
|
|
CLR
914
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $2.98M | 0.01% |
48,567
-623,660
| -93% | -$34.6M |
|
915
TriNet
TNET
$3.18B
| $2.97M | 0.01% |
30,184
-161,085
| -84% | -$14.2M |
|
|
OPLN
916
Openlane
OPLN
$4.28B
| $2.96M | 0.01% |
164,063
-330,856
| -67% | -$5.3M |
|
917
Smith & Wesson
SWBI
$586M
| $2.96M | 0.01% |
195,736
+168,077
| +608% | +$2.82M |
|
|
FFWM
918
DELISTED
First Foundation Inc
FFWM
| $2.96M | 0.01% |
121,757
-44,248
| -27% | -$1.15M |
|
919
Devon Energy
DVN
$53.3B
| $2.95M | 0.01% |
49,932
-58,796
| -54% | -$3.18M |
|
|
CPE
920
DELISTED
Callon Petroleum Company
CPE
| $2.95M | 0.01% |
49,876
-64,175
| -56% | -$3.51M |
|
921
Camden Property Trust
CPT
$11.7B
| $2.95M | 0.01% |
17,724
-1,687
| -9% | -$278K |
|
922
Deere & Co
DE
$181B
| $2.94M | 0.01% |
7,072
+3,372
| +91% | +$1.29M |
|
923
Tronox
TROX
$685M
| $2.93M | 0.01% |
148,224
-20,070
| -12% | -$435K |
|
924
Graphic Packaging
GPK
$2.86B
| $2.93M | 0.01% |
146,210
-119,790
| -45% | -$2.33M |
|
|
UCB
925
United Community Banks
UCB
$4.2B
| $2.93M | 0.01% |
84,070
-9,201
| -10% | -$339K |
|
Similar funds
Federated Hermes's Q1 2022 Portfolio in Review
As of Q1 2022, Federated Hermes held 2,408 positions worth $44.3B, down 18% from $53.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes withdrew a net $5.48B in Q1 2022, closing 238 positions and reducing 967 holdings. Its most notable exit was Nebius Group N.V., an estimated $257M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Technology and Financials.
Against the trend, Federated Hermes opened a new position in Apollo Global Management worth $44.5M.
- Federated Hermes's largest Q1 2022 buy was Apollo Global Management: 718,400 shares worth $44.5M.
- Federated Hermes added most to Clorox in Q1 2022, an estimated $160M increase.
- Federated Hermes's biggest Q1 2022 reduction was TSMC, cutting an estimated $1.01B.
- Federated Hermes fully exited Nebius Group N.V. in Q1 2022, selling an estimated $257M.
- Federated Hermes's ten largest holdings make up 13% of its $44.3B portfolio in Q1 2022.
- Federated Hermes opened 212 new positions and closed 238 in Q1 2022.
- Federated Hermes's portfolio value fell 18% quarter-over-quarter to $44.3B.
Based on Federated Hermes's 13F filing for Q1 2022, filed 13 May 2022.